COVID-19 vaccine may be developed by September – Global Times
|In an interview with the Chinese news outlet, Global Times, George Gao, Director-General of the Chinese Center for Disease Control and Prevention (CDC), said that a vaccine to fight the coronavirus could be developed as early as this September.
Gao noted: “An emergency COVID19 vaccine could be developed by September and a new vaccine following Phase II or III clinical trials may be administered to healthy people by early next year.”
This comes after Reuters reported on Thursday, Gilead Sciences Inc experimental antiviral drug, Remdisivir, failed to help patients with severe COVID-19 in a clinical trial conducted in China.
The news threw the US stocks under the bus while the US dollar rebounded sharply across its main peers.
At the moment, Gao’s comments fail to move the markets, as the Asian equities remain a mixed bag while S&P 500 futures drop 0.70%.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.